(de-news.net) – A large package proposed by the health funding commission aims to stabilize payments amid political and sectoral difficulties, but Minister of Health Nina Warken (CDU) intends to adopt only specific health cost-saving measures, rejecting bigger cutbacks to family co-insurance while supporting focused efficiency reforms.
Warken has indicated that the recommendations advanced by the commission will not be implemented in their entirety, but rather translated into a selective and calibrated package of cost-containment measures. Within this framework, particular resistance has been directed at proposals entailing substantial reductions to family co-insurance, most notably the abolition of contribution-free coverage for spouses without young children. Although the commission’s approach would largely confine exemptions from mandatory insurance to pensioners and parents of pre-school-aged children, Warken has argued for a broader and more differentiated set of exceptions. In doing so, she has underscored the systemic relevance of informal caregiving within families, maintaining that such contributions constitute a socially indispensable function and should not be subjected to additional financial strain through policy adjustments of this kind.
At the same time, the minister has signaled openness to a range of targeted efficiency measures, thereby delineating areas in which reform may proceed. Among these is an increase in patient co-payments for prescription medications to a range of 7.50 to 10 euros per package, a step framed as a moderate recalibration following more than two decades without adjustment. In parallel, the restriction of routine, non-indicated skin cancer screenings has been identified as a potential avenue for expenditure control. Extending this logic of efficiency, Warken has also indicated a willingness to reassess incentive structures in outpatient care, including the possible removal of supplementary remuneration for additional appointments. This position has been justified with reference to prior evaluations suggesting that such extra-budgetary payments did not achieve their intended objective of reducing waiting times, thereby raising questions about their continued effectiveness.
Efficiency measures to advance amid coalition and industry pressures
The commission, convened with the aim of stabilizing statutory health insurance contributions, has put forward a total of 66 proposals that collectively span both expenditure-side and revenue-side interventions. In addition to higher co-payments, these recommendations include fiscal instruments such as increased taxation on alcohol, tobacco, and sugar-sweetened beverages, reflecting a broader effort to diversify funding sources while simultaneously influencing public health outcomes. Nevertheless, the degree of political receptiveness to these measures has varied. While Warken has adopted a critical stance toward contract physicians—particularly in response to arguments linking potential funding reductions to a deterioration in service provision—she has demonstrated comparatively greater understanding for the concerns articulated by the pharmaceutical industry. In this context, she has cautioned against policy choices that could weaken Germany’s attractiveness as an industrial base, while also acknowledging sector-specific challenges, including external trade uncertainties associated with policies pursued by U.S. President Donald Trump.
Against this backdrop, Warken has advanced the position that the pharmaceutical sector should contribute to the broader consolidation effort, yet in a manner that is balanced by targeted relief in regulatory and administrative domains. This dual approach is intended to reconcile cost-containment objectives with the preservation of industrial competitiveness. The overall reform package, for which draft legislation is expected by July, is designed to stabilize the average supplementary contribution rate at 2.9 percent through 2030, thereby providing a degree of medium-term predictability for the statutory system. Although negotiations within the governing coalition—including the SPD—are anticipated to be contentious, the minister has expressed confidence that a politically viable compromise can ultimately be achieved. This expectation rests on a shared recognition among coalition partners that structural adjustments are unavoidable if the sustainability of the solidarity-based health insurance model is to be maintained over the longer term.
Audio: TTSFree
